Montréal InVivo, in brief

Mission and Objectives

Overview and History

Board of Directors

Executive Committee

Working groups

The Research & Innovation Working Group

The Funding Working Group

The Commercialization Working Group

The Visibility Working Group

The Human Resources Strategic Committee

Partners, members and
collaboratorsof Montréal InVivo

Contact us

Working Group Members

Donald Allard
Bristol Myers Squibb

Corine Aubry
MDEIE

Meriem Benmelouka
CTS

François Bergeron
Draximage

Yves Cornellier
Alethia Biotherapeutics,

Alain A. Couture
GSK

Daniel Denis
Secor

Gilles Derome

PEARL, Services de santé

Véronique Gerland
Ville de Montréal

Patrick Hupé
Medtronics-Cryocath

Jean Lachaine
Faculté de pharmacie
Université de Montréal

Yves Lacoursière
sanofi-aventis

Denis Laflamme
Pfizer Canada

Michelle Laflamme
Emovi

Jean-Frédérique Lafontaine
Astra-Zeneca

Jean Morin
Solutions Hospitalis

Christian Ouellet
Novartis

Christina Rabasquinho
Merck Frosst Canada

Savoie, Michelle
Montréal InVivo

Updated: August 23, 2010

Working groups

The Commercialization Working Group

Mandate

Encourage the development of a healthy local, regional and national business environment, suitable for investment and wealth creation;

Montréal InVivo’s role will be to highlight the impact of the solutions proposed by this working group upon the economic health of the entire life sciences and health technologies industry and, more specifically, upon our health.

Issues

Complexity and inertia of the regulatory and legislative environment;

Lack of understanding of the socio-economic potential of the health industry;

Difficulty of access to the Quebec market;

Absence of a functioning network that brings together big pharma and the other actors in the cluster.

Projects

Source : Bilan des activités de Montréal InVivo pour la période du 1er janvier au 31 décembre 2007 (Summary of activities of Montréal InVivo for the period January 1 to December 31 2007)

Development of key messages

Protection of intellectual property

Patient access to care

Participation in OECD discussion group on the future – 2 focus groups (Montréal and Copenhagen), on three subjects:

Emerging biotech business models

Future IP in biotech

P4 Concept

Participation and presentation: InterCluster, Brussells (Belgium)

Strategic advice on the establishment of the Drug Policy

Participation in the CHIP Project

Participation in the Mayor of Montréal’s mission to China

Find us on the Web 2.0 |About Montréal InVivo|The Montréal InVivo Cluster|Sectors of Excellence|Media

Home|Contact us|Français